PRICE T ROWE ASSOCIATES INC /MD/
Position in NRIX — Nurix Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$131,891,600
+$80,892,989 QoQ
Shares Held
5,436,587
+65.2% QoQ
Ownership
5.24%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. NRIX ranks #39 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in NRIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,891,600 | 5,436,587 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $131,891,600 | 5,436,587 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $50,998,611 | 3,290,233 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $61,621,407 | 3,248,361 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,155,618 | 1,099,093 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $34,555,483 | 3,033,844 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $34,610,811 | 2,913,368 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $56,658,040 | 3,007,327 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $68,959,553 | 3,068,961 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $59,168,933 | 2,835,119 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,283,684 | 2,196,169 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $24,664,448 | 2,389,966 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $18,690,906 | 2,377,978 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $23,774,931 | 2,379,873 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,952,588 | 2,584,751 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $35,726,020 | 3,253,736 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $46,990,766 | 3,606,352 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $58,545,827 | 4,620,823 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $67,336,108 | 4,806,289 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $141,017,881 | 4,871,084 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $141,377,554 | 4,718,877 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $107,485,711 | 4,051,478 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $96,183,288 | 3,093,705 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $19,452,991 | 591,636 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $19,645,462 | 562,746 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||